| N |
200 |
| Age (mean) |
61.91 |
| Tumor size mm (mean) |
25.88 |
| Grade% |
|
| 1 |
1 |
| 2 |
31 |
| 3 |
68 |
| Lymph node positive % |
55.5 |
| ER positive % |
77.5 |
| PR-positive % |
59 |
| HER2-positive % |
30.5 |
| HR-positive % |
78.5 |
| TN % |
12 |
| ILC % |
9.5 |
ER: estrogen receptor, PR: progesterone receptor, HER2: human epidermal
growth factor receptor-2; HR: hormone receptor, TN: triple negative, ILC: in situ
lobular carcinoma. |
